Inhibition, control and regression of angiogenesis

Details Inhibition, control and regression of angiogenesis Inhibition, control and regression of angiogenesis

A - Human Necessities

61

K

A61K 47/36 (2006.01) A61K 31/725 (1990.01)

Patent

CA 2121454

The use of: (a) a non-steroidal anti-inflammatory agent, and (b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of hyaluronic acid, in the manufacture of a pharmaceutical composition for inhibiting, controlling and/or regressing angiogenesis in a therapy wherein dosage amounts taken from the composition each comprise: (1) a therapeutically effective amount of component (a); and (2) a therapeutically effective amount of the hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and sub-units of hyaluronic acid, the pharmaceutical composition being characterized in that for each dosage amount taken from the pharmaceutical composition, the amount of components (a) and (b) inhibit, control and/or regress angiogenesis.

Affiliated with

Also associated with

Rating

Inhibition, control and regression of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition, control and regression of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition, control and regression of angiogenesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1947766